Understanding the role of RAD52 in the Alternative Lengthening of Telomeres mechanism.

This PhD project at the University of Birmingham aims to elucidate the molecular mechanisms underlying the Alternative Lengthening of Telomeres (ALT), a telomere maintenance mechanism utilized by 10-15% of all cancers. ALT is a critical process for cellular immortality in cancer cells that do not rely on telomerase, and understanding its molecular basis could have significant implications for cancer biology and therapeutic development. The research will likely involve advanced molecular biology techniques, cellular assays, and possibly biochemical approaches to dissect the pathways and factors involved in ALT. The project is situated within a leading UK research university, offering access to state-of-the-art facilities and a vibrant scientific community. While the position description does not specify funding details, eligibility requirements, or application procedures, prospective students can expect to engage in cutting-edge research at the intersection of molecular biology, oncology, and genome stability. This opportunity is ideal for candidates interested in cancer research, telomere biology, and the development of novel therapeutic strategies.